These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12962369)

  • 1. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study.
    Moroni M; Giannetta L; Gelosa G; Secondino S; Chillura G; Colombo E; Siena S
    J Chemother; 2003 Aug; 15(4):394-9. PubMed ID: 12962369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
    Iop A; Cartei G; Isaia A
    Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
    J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival.
    Conroy T; Etienne PL; Adenis A; Ducreux M; Paillot B; Oliveira J; Seitz JF; Francois E; Van Cutsem E; Wagener DJ; Kohser F; Daamen S; Praet M; Gorlia T; Baron B; Wils J;
    Ann Oncol; 2002 May; 13(5):721-9. PubMed ID: 12075740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for cytostatic therapy of recurrent cancer].
    Schröder M; Stennert E; von Heyden HW; Scherpe A
    HNO; 1984 Jun; 32(6):245-8. PubMed ID: 6206035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin.
    Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ
    Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
    von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
    Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine].
    von Heyden HW; Schröder M; Scherpe A; Beyer JH; Kaboth U; Stennert E; Nagel GA; Gerhartz H; Foth B; Kastenbauer E
    Onkologie; 1984 Jun; 7(3):183-90. PubMed ID: 6205337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
    Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
    Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck.
    Gebbia V; Testa A; Di Gregorio C; Ingria F; Valenza R; Cannata G; Moschella F; Restivo G; Gebbia N
    Am J Clin Oncol; 1995 Aug; 18(4):293-6. PubMed ID: 7625368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.